MAGT1 and central nervous system cancer: Altogether, our in vivo data, consistent with in vitro results, substantiated that MAGT1 could upregulate the expression of PD-L1 by activating the ERK signaling pathway, thereby stimulating the growth of glioma cells in vivo.